Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

ISONIAZID 100 MG TABLET

isoniazid
$1.6785per EA

Strength

100 mg/1

Manufacturer

Genus Lifesciences Inc.

NDC

64950021610

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

ISONIAZID

Approval Type

Generic (ANDA)

FDA Application

ANDA080936

On Market Since

11/1/2024

Pharmacological Classes

Antimycobacterial

Price History

1W

0.0%

1M

+1.7%

3M

+3.4%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

+4.8%

Generic Alternatives

1 alternative • Same active ingredient

ISONIAZID 100 MG TABLET
Generic
81665010710•Omnivium Pharmaceuticals LLC
$1.6785

Related Drugs

Same classification

ETHAMBUTOL HCL 100 MG TABLET
Generic
42806010101•Epic Pharma LLC
$0.3332
per EA
ETHAMBUTOL HCL 100 MG TABLET
Generic
68180028001•Lupin Pharmaceuticals Inc.
$0.3332
per EA
ETHAMBUTOL HCL 100 MG TABLET
Generic
54879000101•STI Pharma LLC
$0.3452
per EA
ETHAMBUTOL HCL 400 MG TABLET
Generic
42806010201•Epic Pharma LLC
$0.4493
per EA
ETHAMBUTOL HCL 400 MG TABLET
Generic
68084028001•American Health Packaging
$0.4493
per EA
ETHAMBUTOL HCL 400 MG TABLET
Generic
68180028101•Lupin Pharmaceuticals Inc.
$0.4493
per EA
ETHAMBUTOL HCL 400 MG TABLET
Generic
54879000201•STI Pharma LLC
$0.4866
per EA
PYRAZINAMIDE 500 MG TABLET
Generic
00054081221•Hikma Pharmaceuticals USA Inc.
$1.5768
per EA
PYRAZINAMIDE 500 MG TABLET
Generic
00054081222•Hikma Pharmaceuticals USA Inc.
$1.5768
per EA
PYRAZINAMIDE 500 MG TABLET
Generic
00054081225•Hikma Pharmaceuticals USA Inc.
$1.5768
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy